Description
Integrity Oncology represents an emerging approach in cancer care that emphasizes transparency, ethical decision-making, and data-driven treatment strategies. Its promise lies in fostering patient trust, enabling more personalized therapies, and ensuring that clinical decisions are grounded in accurate, unbiased evidence. With advancements in genomics, digital health, and real-world data, Integrity Oncology has the potential to significantly improve outcomes and streamline care pathways. However, challenges remain, including data privacy concerns, variability in care standards, and the need for stronger regulatory frameworks to maintain true integrity across systems. Addressing these barriers is essential for realizing the full potential of this transformative model in oncology.
Summary Listen
- Cancer is becoming increasingly prevalent globally, with premature aging at the cellular level being a major underlying factor. Biological age, reflecting DNA damage, often exceeds chronological age due to modern lifestyle factors like pollutants and dietary habits.
- Ayurveda views life as a journey to 100 years of health and emphasizes slowing down aging ("mandajjara") through therapies like Panchakarma. Premature aging ("akala jara") manifests in various signs, including muscle loss, joint inflammation, blood toxicity, fat accumulation, and decreased bone marrow density.
- Modern oncology identifies oncogenes and tumor suppressor genes as key regulators of cell division. Mitochondrial dysfunction, caused by toxins and poor lifestyle choices, leads to reactive oxygen species, epigenetic malformations, and uncontrolled cell splitting (tumorogenesis).
- Ayurveda's "Paramano" theory, predating modern cellular biology, describes "Paramano" as the smallest units, with joining (Samyoga) and splitting (Vibhaga) forces at play. Imbalances are influenced by Vayu (energy), Karma (lifestyle), and Sotava (genetics).
- Environmental factors are key in cancer development, impacting mitochondrial function ("Agni" in Ayurveda) and leading to toxin accumulation ("Malah"). "Apakku Tha too," immature cells, and aggravated Vata, Pitha, and Kapha doshas contribute to "Arbhuda" (tumor) formation.
- Recta-Jah Bhudas, tumors originating from blood, are highly vascularized, bleed easily, and metastasize quickly. Ayurveda identifies specific areas prone to these tumors, based on their inherent vascularity.
- Ayurveda can complement conventional oncology in cases where patients cannot undergo standard treatments, to manage side effects of chemotherapy and radiation, for treatment-resistant tumors, and in palliative care. Ayurvedic interventions include herbal remedies, dietary modifications, Pranayama, and yoga to improve immunity and reduce tumor load.
- Several case studies demonstrate the potential of Ayurveda in treating cancers like leukemia, myelodysplastic syndrome (MDS), Kaposi sarcoma, breast cancer, and Burkitt lymphoma, often achieving remission and improving survival rates. Ayurveda can also be effective against autoimmune diseases such as Pemphigus Vulgaris.
Sample Certificate
About the Speakers
Dr. Rajagopal Krishnan
Chief Physician, Dr. Rajagopal\'s Ayur Cancer Care (Centre of Integrative Oncology and Autoimmune Research), Kollam, Kerala
Comments
Comments
You must be logged in to leave a comment.